The 5-year analysis of Strides Pharma Science Ltd's performance infers:
Strides Pharma Science Ltd earnings have declined by -12.9%, whereas share price has depreciated -3.5% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.